Sequenom Announces Sale of Five MassArray Systems | GenomeWeb

NEW YORK, July 10 – Sequenom of San Diego said Tuesday it had sold five MassArray systems, bringing the number sold in the second quarter to nine.

The purchasers include BioServe Biotechnologies, Centagenetix, Indiana University School of Medicine, LGC, and an undisclosed party. 

"We continue to experience an increasing demand for our MassArray product line," Toni Schuh, CEO of Sequenom, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.